- GEMTESA was effective in treating the symptoms of OAB in a 12-week clinical trial1
- Symptoms treated include urge urinary incontinence, urgency, and urinary frequency1
The information contained in this section of the site is intended for US healthcare professionals only. If you are not a healthcare professional, please select CANCEL.
Reference: 1. GEMTESA [prescribing information] Irvine, CA. Urovant Sciences, GmbH.